90 related articles for article (PubMed ID: 22630105)
21. Kaposi's sarcoma. An Update.
Zalla MJ
Dermatol Surg; 1996 Mar; 22(3):274-87. PubMed ID: 8599740
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
[TBL] [Abstract][Full Text] [Related]
23. Kaposi'S sarcoma of the stomach and duodenum in human immunodeficiency virus infection.
Kibria R; Siraj U; Barde C
Dig Endosc; 2010 Jul; 22(3):241-2. PubMed ID: 20642618
[TBL] [Abstract][Full Text] [Related]
24. Noncytotoxic approaches to the treatment of HIV-associated Kaposi's sarcoma.
Pluda JM; Parkinson DR; Feigal E; Yarchoan R
Oncology (Williston Park); 1993 Dec; 7(12):25-33; discussion 33, 37-8. PubMed ID: 8292505
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma of an intraparotid lymph node leading to a diagnosis of HIV.
Steele NP; Sampogna D; Sessions RB
Laryngoscope; 2005 May; 115(5):861-3. PubMed ID: 15867654
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma: a comprehensive review.
Aquino L; Aquino MD; Aquino JM
J Foot Surg; 1986; 25(1):78-81. PubMed ID: 3512685
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma associated with AIDS.
Stănescu L; Foarfă C; Georgescu AC; Georgescu I
Rom J Morphol Embryol; 2007; 48(2):181-7. PubMed ID: 17641807
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
[TBL] [Abstract][Full Text] [Related]
31. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo RC; Ensoli B
J Immunol; 1992 Dec; 149(11):3727-34. PubMed ID: 1431144
[TBL] [Abstract][Full Text] [Related]
32. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma with visceral involvement in a young heterosexual male without evidence of the acquired immune deficiency syndrome.
Kumar S; Schade RR; Peel R; Lehar SC; Joyce R; Van Thiel DH
Am J Gastroenterol; 1989 Mar; 84(3):318-21. PubMed ID: 2919591
[TBL] [Abstract][Full Text] [Related]
34. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
[TBL] [Abstract][Full Text] [Related]
35. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.
Radka SF; Nakamura S; Sakurada S; Salahuddin SZ
J Immunol; 1993 Jun; 150(11):5195-201. PubMed ID: 8098726
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries.
Bisacchi D; Noonan DM; Carlone S; Albini A; Pfeffer U
Biol Chem; 2002 Sep; 383(9):1315-20. PubMed ID: 12437123
[TBL] [Abstract][Full Text] [Related]
37. Cytokine profile of HIV-positive Kaposi's sarcoma derived cells in vitro.
Brockmeyer NH; Willers CP; Anders S; Mertins L; Rockstroh JK; Stürzl M
Eur J Med Res; 1999 Mar; 4(3):95-100. PubMed ID: 10085275
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma as a sexually transmissible infection: an analysis of Australian AIDS surveillance data. The National HIV Surveillance Committee.
Elford J; McDonald A; Kaldor J
AIDS; 1993 Dec; 7(12):1667-71. PubMed ID: 8286078
[TBL] [Abstract][Full Text] [Related]
39. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
40. Pathogenetic role of HIV infection in Kaposi's sarcoma of equatorial East Africa.
Craighead J; Moore A; Grossman H; Ershler W; Frattini U; Saxinger C; Hess U; Ngowi F
Arch Pathol Lab Med; 1988 Mar; 112(3):259-65. PubMed ID: 3257865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
